MDC.L

Mediclinic International Plc
Magnetar Capital Partners LP - Form 8.3 - Mediclinic International Plc
24th May 2023, 12:44
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
                                                                       FORM 8.3

           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

                  Rule 8.3 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser:                       Magnetar Capital Partners LP

(b) Owner or controller of interests and short
positions disclosed, if different from 1(a):
     The naming of nominee or vehicle companies
is insufficient.  For a trust, the trustee(s),
settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose  Mediclinic International plc
relevant securities this form relates:
     Use a separate form for each offeror/offeree

(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity
of offeror/offeree:

(e) Date position held/dealing undertaken:        23/05/2023
     For an opening position disclosure, state
the latest practicable date prior to the
disclosure

(f)  In addition to the company in 1(c) above, is NO
the discloser making disclosures in respect of
any other party to the offer?
     If it is a cash offer or possible cash
offer, state "N/A"

2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one
class of relevant securities of the offeror or offeree named in 1(c), copy
table 2(a) or (b) (as appropriate) for each additional class of relevant
security.

(a)        Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the dealing (if
any)

Class of relevant security:                        10p ordinary

                                         Interests           Short positions

                                       Number        %         Number        %

(1) Relevant securities owned and
/or controlled:

(2) Cash-settled derivatives:        15,233,047     2.06

(3) Stock-settled derivatives
(including options) and
agreements to purchase/sell:

                                     15,233,047     2.06
     TOTAL:

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded
options), or agreements to purchase or sell relevant securities, should be
given on a Supplemental Form 8 (Open Positions).

(b)        Rights to subscribe for new securities (including directors' and
other employee options)

Class of relevant security in relation
to which subscription right exists:

Details, including nature of the rights
concerned and relevant percentages:

3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as
appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

   Class of relevant       Purchase/sale    Number of   Price per unit
        security                            securities

(b)        Cash-settled derivative transactions

  Class of     Product       Nature of       Number of     Price per
  relevant   description      dealing        reference        unit
  security     e.g. CFD    e.g. opening/    securities
                          closing a long/
                          short position,
                            increasing/
                          reducing a long
                          /short position

   Common        Swap      Increasing a        7,710      GBP5.005000
                           long position

   Common        Swap      Increasing a         401       GBP5.000012
                           long position

   Common        Swap      Increasing a         437       GBP5.000023
                           long position

(c)        Stock-settled derivative transactions (including options)

(i)         Writing, selling, purchasing or varying

Class of   Product    Writing,   Number of  Exercise    Type    Expiry   Option
relevant description purchasing, securities price per   e.g.     date    money
security  e.g. call   selling,    to which    unit    American,          paid/
           option      varying     option             European          received
                        etc.      relates               etc.            per unit

(ii)        Exercise

   Class of         Product      Exercising/      Number of     Exercise price per
   relevant       description     exercised      securities            unit
   security     e.g. call option   against

(d)        Other dealings (including subscribing for new securities)

Class of relevant     Nature of dealing           Details      Price per unit (if
    security          e.g. subscription,                           applicable)
                          conversion

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or
understanding, formal or informal, relating to relevant securities which may be
an inducement to deal or refrain from dealing entered into by the person making
the disclosure and any party to the offer or any person acting in concert with
a party to the offer:
Irrevocable commitments and letters of intent should not be included.  If there
are no such agreements, arrangements or understandings, state "none"


None

(b)        Agreements, arrangements or understandings relating to options or
derivatives

Details of any agreement, arrangement or understanding, formal or informal,
between the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant
securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"


None

(c)        Attachments

Is a Supplemental Form 8 (Open Positions) attached?                      NO



Date of disclosure:                      24/05/2023

Contact name:                            Julianna Ethell

Telephone number:                        847-905-4688

Public disclosures under Rule 8 of the Code must be made to a Regulatory
Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation
to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

TwitterFacebookLinkedIn